Alector, Inc. (ALEC) stock
ALECNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.57+0.01 (+0.39%)
Close on Nov 18, 2026Market cap $286.96MP/E –Yield –
Alector net income
Net income is the profit left for shareholders after every expense, interest and tax.
Alector's net income for the twelve months ending Jun 30, 2026 was -$117.85M. For fiscal 2025 it was -$142.93M. The highest annual figure on record is -$32.48M in fiscal 2017.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$142.93M | – |
| FY2024 | Dec 31, 2024 | -$119.05M | – |
| FY2023 | Dec 31, 2023 | -$130.39M | – |
| FY2022 | Dec 31, 2022 | -$133.31M | – |
| FY2021 | Dec 31, 2021 | -$36.33M | – |
| FY2020 | Dec 31, 2020 | -$190.23M | – |
| FY2019 | Dec 31, 2019 | -$105.39M | – |
| FY2018 | Dec 31, 2018 | -$52.25M | – |
| FY2017 | Dec 31, 2017 | -$32.48M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$22.99M | – |
| Q1 FY2026 | Mar 31, 2026 | -$22.93M | – |
| Q4 FY2025 | Dec 31, 2025 | -$37.27M | – |
| Q3 FY2025 | Sep 30, 2025 | -$34.67M | – |
| Q2 FY2025 | Jun 30, 2025 | -$30.52M | – |
| Q1 FY2025 | Mar 31, 2025 | -$40.47M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.07M | – |
| Q3 FY2024 | Sep 30, 2024 | -$42.22M | – |
| Q2 FY2024 | Jun 30, 2024 | -$38.68M | -2912.8% |
| Q1 FY2024 | Mar 31, 2024 | -$36.08M | – |
| Q4 FY2023 | Dec 31, 2023 | -$41.43M | – |
| Q3 FY2023 | Sep 30, 2023 | -$44.48M | – |
| Q2 FY2023 | Jun 30, 2023 | $1.38M | -86.1% |
| Q1 FY2023 | Mar 31, 2023 | -$45.86M | – |
| Q4 FY2022 | Dec 31, 2022 | -$52.43M | – |
| Q3 FY2022 | Sep 30, 2022 | -$46.15M | -136.5% |
| Q2 FY2022 | Jun 30, 2022 | $9.88M | – |
| Q1 FY2022 | Mar 31, 2022 | -$44.62M | – |
| Q4 FY2021 | Dec 31, 2021 | -$55.61M | – |
| Q3 FY2021 | Sep 30, 2021 | $126.60M | – |
| Q2 FY2021 | Jun 30, 2021 | -$55.15M | – |
| Q1 FY2021 | Mar 31, 2021 | -$52.17M | – |
| Q4 FY2020 | Dec 31, 2020 | -$52.18M | – |
| Q3 FY2020 | Sep 30, 2020 | -$52.70M | – |
| Q2 FY2020 | Jun 30, 2020 | -$45.33M | – |
| Q1 FY2020 | Mar 31, 2020 | -$40.02M | – |
| Q4 FY2019 | Dec 31, 2019 | -$30.53M | – |
| Q3 FY2019 | Sep 30, 2019 | -$31.74M | – |
| Q2 FY2019 | Jun 30, 2019 | -$24.56M | – |
| Q1 FY2019 | Mar 31, 2019 | -$18.56M | – |
| Q4 FY2018 | Dec 31, 2018 | -$17.37M | – |
| Q3 FY2018 | Sep 30, 2018 | -$15.32M | – |
| Q2 FY2018 | Jun 30, 2018 | -$11.12M | – |
| Q1 FY2018 | Mar 31, 2018 | -$8.44M | – |
See a number that looks wrong?